A multicenter study to assess outcome following a switch in the primary immunosuppressant from cyclosporin (CYA) to tacrolimus (TAC) in lung recipients

J Heart Lung Transplant. 2001 Feb;20(2):208. doi: 10.1016/s1053-2498(00)00448-4.

¹ 1University of Vienna, Vienna, Austria; 2Hospital Erasme, Brussels, Belgium; 3St. Vincent's Hospital, Sydney, Australia; 4University of Ziekenhuizen, Leuven, Belgium; 5University of Lausanne, Lausanne, Switzerland; 6University of Geneva, Geneva, Switzerland; 7University of Kiel, Kiel, Germany; 8University of Grosshadern, Munich, Germany

No abstract available